Healthcare · Biotechnology · NASDAQ
| Market cap | $125.73B |
|---|---|
| Trailing P/E | 26.1 |
| FCF yield | 2.5% |
| Revenue growth (YoY) | +8.9% |
| EPS growth (YoY) | +6248.3% |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
Vertex Pharmaceuticals Incorporated trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Lisa McClain | House | Sell | $1,001 - $15,000 | Aug 13, 2025 |
| Jefferson Shreve | House | Sell | $15,001 - $50,000 | May 15, 2025 |
| Byron Donalds | House | Sell | $1,001 - $15,000 | Apr 7, 2025 |
| Jefferson Shreve | House | Buy | $15,001 - $50,000 | Mar 1, 2025 |
| William R. Keating | House | Buy | $1,001 - $15,000 | May 2, 2022 |
| Peter Meijer | House | Sell | $1,001 - $15,000 | Feb 3, 2021 |
| Dean Phillips | House | Buy | $1,001 - $15,000 | Jan 7, 2021 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Oct 7, 2019 |
| Donna Shalala | House | Sell | $1,001 - $15,000 | Jun 30, 2019 |
| Donna Shalala | House | Buy | $1,001 - $15,000 | Apr 30, 2019 |
| John F Reed | Senate | Sell | $1,001 - $15,000 | — |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Aug 8, 2018 |